Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000353125

Medchemexpress LLC AMXI-5001 hydrochloride | 2170491-77-5 | 98.1% | C25H21ClFN5O3 | 25 MG
SDP

Catalog No. 5000353125
Encompass_Preferred

AMXI-5001 hydrochloride is a potent, orally active, dual PARP1/2 and microtubule polymerization inhibitor. It shows selective antitumor cytotoxicity against various human cancer cells with significantly lower IC50s compared to existing clinical PARP1/2 inhibitors. This compound has been observed to induce complete regression of established tumors, even exceedingly large ones.

  • Potent, orally active, dual PARP1/2 and microtubule polymerization inhibitor
  • Shows selective antitumor cytotoxicity against various human cancer cells
  • Significantly lower IC50s compared to existing clinical PARP1/2 inhibitors
  • Induces complete regression of established tumors, even exceedingly large ones

Catalog No. 50-003-53125 Supplier Medchemexpress LLC Supplier No. 25MGHY145734A
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

AMXI-5001 hydrochloride is a potent, orally active, dual PARP1/2 and microtubule polymerization inhibitor. It shows selective antitumor cytotoxicity against various human cancer cells with significantly lower IC50s compared to existing clinical PARP1/2 inhibitors. This compound has been observed to induce complete regression of established tumors, even exceedingly large ones.

  • Potent, orally active, dual PARP1/2 and microtubule polymerization inhibitor
  • Shows selective antitumor cytotoxicity against various human cancer cells
  • Significantly lower IC50s compared to existing clinical PARP1/2 inhibitors
  • Induces complete regression of established tumors, even exceedingly large ones

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.